Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 (RESPIRE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04776044 |
|
Recruitment Status :
Terminated
(general circumstances around COVID-19 and current availability of hospitalized patients)
First Posted : March 1, 2021
Last Update Posted : September 22, 2022
|
Sponsor:
Atriva Therapeutics GmbH
Information provided by (Responsible Party):
Atriva Therapeutics GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 6, 2022 |
| Actual Study Completion Date : | August 9, 2022 |